Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX).
- Disclosed ownership: 5.5%.
- Date of event: 06 Oct 2025.
PERCEPTIVE ADVISORS LLC - 06 Oct 2025 SCHEDULE 13G Report for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- TVTX
- Shares outstanding
- 89,011,182 shares
- Disclosed Ownership
- 4,895,615 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Oct 2025, 09:24:04 UTC
- Date of event
- 06 Oct 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 5.5% ownership in TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX) on 06 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Oct 2025, 09:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 5.5% | 4,895,615 | 0 | 4,895,615 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 5.5% | 4,895,615 | 0 | 4,895,615 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 5.5% | 4,895,615 | 0 | 4,895,615 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |